ArticleAnnals of medicine and surgery (2012)2025
Protective eye device for eyelid brachytherapy: Technical report of an innovative personalized method.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Carcinoma of the eyelid is a specific anatomical variant of skin cancer, notable for its proximity to the eye. Surgery is the gold standard for managing eyelid cancer, while radiotherapy can serve as an alternative for patients unfit for surgery or as an adjunct treatment. Various devices in maxillofacial prosthodontics are used in conjunction with head and neck radiotherapy to protect the healthy tissues surrounding the irradiation site. These devices are designed by a maxillofacial prosthodontics specialist in collaboration with a radiotherapist/oncologist. Case presentation: This technical report presents an innovative and original method for an eye protection device against radiation. We describe a case involving a 60-year-old woman with basal cell carcinoma of the eyelid, initially treated with surgical excision. High-dose rate brachytherapy was indicated, with a total dose of 40 Gy administered in 8 fractions. Prior to treatment delivery, it was necessary to protect the eyeball from the adverse effects of eyelid BT. We devised a novel device to shield the eyeball and its adnexa. Clinical discussion: This article details the technique for the creation and insertion of this device. To our knowledge, this is the first reported case of an intraocular protective device made with lead. This invention was patented under the reference [MA 56825 B1]. Conclusion: The use of a stent designed to shield adjacent tissues from the side effects of radiotherapy is highly advantageous, particularly for critical sites such as the one presented in this clinical case. The success of eye protection in this instance is encouraging and suggests the potential to expand the application of similar devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.